Off the wire
Aussie researchers develop database detailing fish caught since 1950  • Gold price opens higher in Hong Kong  • Hong Kong stocks open 0.08 percent lower  • Students at Australia's top universities among "least satisfied": report  • Japan's core private-sector machinery orders up 1.5 pct in Feb.  • 1st LD Writethru: 6.0-magnitude earthquake jolts S. Philippines  • Xinhua world news summary at 0100 GMT, April 12  • Tokyo stocks open lower as yen's rise on geopolitical concerns impacts exporters  • Dollar changes hands in upper 109 yen range in early trade in Tokyo  • India becomes biggest source of migration to Aust'n state for first time: census  
You are here:   Home

Method to stop cancer from mutating and spreading developed by Australian researchers

Xinhua, April 12, 2017 Adjust font size:

Australian scientists have made a breakthrough in preventing cancer from mutating in the body.

The team from Melbourne's Olivia Newton-John (ONJ) Cancer Wellness and Research Centre have been able to interrupt the body's wound-healing process and lock cancer cells into a "harmless" state before they can mutate and spread.

The process has proved successful in treating colon and stomach cancer and lead researcher Matthias Ernst believes it could be applied to other cancers.

Instead of targeting cancer cells themselves, the ONJ breakthrough interrupts a white blood cell process called macrophages which has been known to fight cancer.

However, if the macrophage cells are exposed to a wound then the HCK protein signals the cells to take on a nursing role, prompting extra skin cells to grow and cover the wound.

The research team discovered that cancer cells can hijack the healing properties and use white blood cells to fuel their own growth rather than skin cells.

By blocking the HCK protein and preventing the macrophage cells from changing to a nursing role to begin with, Ernst's team has been able to suppress the growth of established tumours.

"We have identified a way you can therapeutically target the non-mutated cells in a cancer. The advantage of that is because they are non-mutated they are less likely to develop resistance," Ernst told News Limited on Wednesday.

"We know very well how to inhibit these molecules, and therefore it is very foreseeable on how you would develop a drug that can inhibit the activity of the HCK and therefore lock the macrophage into garbage collector state and rather than allowing them to become nurses."

Ernst said his team was currently working to develop a drug capable of safely freezing the process with human clinical trials on the horizon. Endit